v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (6,498,068) $ (6,993,647)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,725 1,724
Stock-based compensation 1,010,631 943,649
Non-cash consideration received pursuant to revenue agreements (116,670)
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 11,185 34,285
Accounts payable (267,783) 332,278
Accrued expenses 336,715 71,462
Net cash used in operating activities (5,522,265) (5,610,249)
Cash flows from investing activities:    
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from sale of common stock from ATM, net of issuance costs 2,467,533
Proceeds from issuance of common stock and warrants, net of issuance costs 8,315,686
Proceeds from warrant exercises 105,816
Issuance costs paid in advance of equity financing (92,546)
Proceeds from short term insurance financing 181,797 561,885
Payments on short term insurance financing (181,797) (561,885)
Net cash provided by financing activities 2,374,987 8,421,502
Net (decrease) increase in cash and cash equivalents (3,147,278) 2,811,253
Cash and cash equivalents and restricted cash, beginning of period 5,435,983 2,624,730
Cash and cash equivalents and restricted cash, end of period 2,288,705 5,435,983
Supplemental cash flow information:    
Cash paid for interest 5,629 18,158
Cash paid for taxes
Supplemental non-cash activity    
Issuance of common stock as commitment fee in advance of equity transaction $ 207,493

Source

HTML PDF
ZIP